Clinical Trial

Decitabine for Poor Graft Function Post Allo-HSCT

Name: Decitabine for Poor Graft Function Post Allo-HSCT — clinical trial record (NCT05907499)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated June 18, 2023 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

This randomized trial aims at validating the efficacy and safety of low-dose decitabine for PGF post allo-HSCT.

Trial Details

NCT Number	NCT05907499
Lead Sponsor	The First Affiliated Hospital of Soochow University
Conditions	Poor Graft Function
Enrollment	76 participants
Start Date	2023-07-01
Primary Completion	2026-07-01 (estimated)
Study Completion	2026-11-01 (estimated)
Updated on ClinicalTrials.gov	2023-06-18